AAAAAA

   
Results: 1-12 |
Results: 12
CLINICOPATHOLOGICAL ANALYSIS OF FOLLICULAR LYMPHOMA WITH A POLYPLOID KARYOTYPE
Authors: JAMES GK HORSMAN D CONNORS JM KLASA R WILSON K ARGATOFF L GASCOYNE RD
Citation: Gk. James et al., CLINICOPATHOLOGICAL ANALYSIS OF FOLLICULAR LYMPHOMA WITH A POLYPLOID KARYOTYPE, Leukemia & lymphoma, 28(3-4), 1998, pp. 383-389
T(2-5) POSITIVE LYMPHOMA WITH PERIPHERAL-BLOOD INVOLVEMENT
Authors: CHHANABHAI M BRITTEN C KLASA R GASCOYNE RD
Citation: M. Chhanabhai et al., T(2-5) POSITIVE LYMPHOMA WITH PERIPHERAL-BLOOD INVOLVEMENT, Leukemia & lymphoma, 28(3-4), 1998, pp. 415-422
ANTISENSE BCL2 OLIGONUCLEOTIDES INHIBIT PROGRESSION TO ANDROGEN-INDEPENDENCE AFTER CASTRATION IN THE LNCAP TUMOR-MODEL
Authors: GLEAVE M TOLCHER A KLASA R GOLDIE J BROWN B
Citation: M. Gleave et al., ANTISENSE BCL2 OLIGONUCLEOTIDES INHIBIT PROGRESSION TO ANDROGEN-INDEPENDENCE AFTER CASTRATION IN THE LNCAP TUMOR-MODEL, The Journal of urology, 159(5), 1998, pp. 23-23
ADVANCED DIFFUSE LARGE-CELL LYMPHOMA TREATED WITH 12-WEEK COMBINATIONCHEMOTHERAPY - NATURAL-HISTORY OF RELAPSE AFTER INITIAL COMPLETE RESPONSE AND PROGNOSTIC VARIABLES DEFINING OUTCOME AFTER RELAPSE
Authors: HOSKINS PJ LE N GASCOYNE RD KLASA R SHENKIER T OREILLY S CONNORS JM
Citation: Pj. Hoskins et al., ADVANCED DIFFUSE LARGE-CELL LYMPHOMA TREATED WITH 12-WEEK COMBINATIONCHEMOTHERAPY - NATURAL-HISTORY OF RELAPSE AFTER INITIAL COMPLETE RESPONSE AND PROGNOSTIC VARIABLES DEFINING OUTCOME AFTER RELAPSE, Annals of oncology, 8(11), 1997, pp. 1125-1132
MALIGNANT-LYMPHOMAS IN THE ELDERLY
Authors: OREILLY SE CONNORS JM MACPHERSON N KLASA R HOSKINS P
Citation: Se. Oreilly et al., MALIGNANT-LYMPHOMAS IN THE ELDERLY, Clinics in geriatric medicine, 13(2), 1997, pp. 251
THE PROGNOSTIC-SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN FOLLICULAR LYMPHOMAS (FL)
Authors: GASCOYNE RD ARGATOFF L JAMES G KLASA R WILSON K CONNORS JM HORSMAN DE
Citation: Rd. Gascoyne et al., THE PROGNOSTIC-SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN FOLLICULAR LYMPHOMAS (FL), Laboratory investigation, 76(1), 1997, pp. 731-731
CPF (CYCLOPHOSPHAMIDE, PREDNISONE, FLUDARABINE) IN ADVANCED-STAGE PREVIOUSLY UNTREATED LOW-GRADE AND MANTLE CELL LYMPHOMA
Authors: KLASA R CONNORS J GASCOYNE R HOSKINS P OREILLY S SHENKIER T
Citation: R. Klasa et al., CPF (CYCLOPHOSPHAMIDE, PREDNISONE, FLUDARABINE) IN ADVANCED-STAGE PREVIOUSLY UNTREATED LOW-GRADE AND MANTLE CELL LYMPHOMA, Blood, 90(10), 1997, pp. 1527-1527
GLUCOCORTICOID DOSE-RELATED SUSCEPTIBILITY TO INFECTION IN MYELOMA PATIENTS TREATED WITH MELPHALAN
Authors: SHUSTIK C JOHNSTON D JAMES K ZEE B MYER R BELCH A KLASA R MEHARCHAND J PATER J
Citation: C. Shustik et al., GLUCOCORTICOID DOSE-RELATED SUSCEPTIBILITY TO INFECTION IN MYELOMA PATIENTS TREATED WITH MELPHALAN, Blood, 90(10), 1997, pp. 1596-1596
CYTOGENETIC HETEROGENEITY OF SMALL NONCLEAVED, NON-BURKITTS LYMPHOMA
Authors: GASCOYNE RD LESACK D MACPHERSON N KLASA R CONNORS JM HORSMAN DE
Citation: Rd. Gascoyne et al., CYTOGENETIC HETEROGENEITY OF SMALL NONCLEAVED, NON-BURKITTS LYMPHOMA, Laboratory investigation, 74(1), 1996, pp. 648-648
PHASE-II STUDY OF SUBCUTANEOUS RHU-INTERLEUKIN-2 AND RHU-INTERFERON ALPHA-2A IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE-MYELOMA
Authors: BELCH AR EISENHAUER EA MULDAL A BROWMAN G KLASA R OSTERWALDER B
Citation: Ar. Belch et al., PHASE-II STUDY OF SUBCUTANEOUS RHU-INTERLEUKIN-2 AND RHU-INTERFERON ALPHA-2A IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE-MYELOMA, Annals of oncology, 6(7), 1995, pp. 721-723
HIGH-DOSE CYCLOPHOSPHAMIDE BCNU, VP16-213+ -CISPLATIN (CBV+/-P) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR PATIENTS (PTS) WITH HODGKINS-DISEASE (HD) WHO FAIL TO ENTER A COMPLETE REMISSION (CR) AFTER COMBINATION CHEMOTHERAPY/
Authors: SPINELLI RD BARNETT M CONNORS J HOGGE D KLINGEMANN D FAIREY H KLASA R OREILLY NS SHEPHERD I VOSS N SUTHERLAND H PHILLIPS G
Citation: Rd. Spinelli et al., HIGH-DOSE CYCLOPHOSPHAMIDE BCNU, VP16-213+ -CISPLATIN (CBV+/-P) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR PATIENTS (PTS) WITH HODGKINS-DISEASE (HD) WHO FAIL TO ENTER A COMPLETE REMISSION (CR) AFTER COMBINATION CHEMOTHERAPY/, Blood, 84(10), 1994, pp. 10000162-10000162
IN SEARCH OF AN OPTIMAL REGIMEN FOR ELDERLY PATIENTS WITH ADVANCED-STAGE DIFFUSE LARGE-CELL LYMPHOMA - RESULTS OF A PHASE-II STUDY OF P-DOCE CHEMOTHERAPY
Authors: OREILLY SE CONNORS JM HOWDLE S HOSKINS P KLASA R KLIMO P STUART DS
Citation: Se. Oreilly et al., IN SEARCH OF AN OPTIMAL REGIMEN FOR ELDERLY PATIENTS WITH ADVANCED-STAGE DIFFUSE LARGE-CELL LYMPHOMA - RESULTS OF A PHASE-II STUDY OF P-DOCE CHEMOTHERAPY, Journal of clinical oncology, 11(11), 1993, pp. 2250-2257
Risultati: 1-12 |